These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8988031)

  • 21. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel gene fusion of COX6C at 8q22-23 to HMGIC at 12q15 in a uterine leiomyoma.
    Kurose K; Mine N; Doi D; Ota Y; Yoneyama K; Konishi H; Araki T; Emi M
    Genes Chromosomes Cancer; 2000 Mar; 27(3):303-7. PubMed ID: 10679920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of PLAG1 gene rearrangements in pleomorphic adenoma.
    Kandasamy J; Smith A; Diaz S; Rose B; O'Brien C
    Cancer Genet Cytogenet; 2007 Aug; 177(1):1-5. PubMed ID: 17693184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
    Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
    Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal translocation t(8;12) induces aberrant HMGIC expression in aggressive angiomyxoma of the vulva.
    Nucci MR; Weremowicz S; Neskey DM; Sornberger K; Tallini G; Morton CC; Quade BJ
    Genes Chromosomes Cancer; 2001 Oct; 32(2):172-6. PubMed ID: 11550285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements.
    Rohen C; Rogalla P; Meyer-Bolte K; Bartnitzke S; Chilla R; Bullerdiek J
    Cancer Genet Cytogenet; 1999 Jun; 111(2):178-81. PubMed ID: 10347561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors.
    Kazmierczak B; Dal Cin P; Wanschura S; Bartnitzke S; Van den Berghe H; Bullerdiek J
    Am J Pathol; 1998 Feb; 152(2):431-5. PubMed ID: 9466569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions.
    Meza-Zepeda LA; Berner JM; Henriksen J; South AP; Pedeutour F; Dahlberg AB; Godager LH; Nizetic D; Forus A; Myklebost O
    Genes Chromosomes Cancer; 2001 Jul; 31(3):264-73. PubMed ID: 11391797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
    Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
    Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Fragile Histidine Triad gene and breast cancer.
    Yang Q; Yoshimura G; Sakurai T; Kakudo K
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma.
    Schoenmakers EF; Kools PF; Mols R; Kazmierczak B; Bartnitzke S; Bullerdiek J; Dal Cin P; De Jong PJ; Van den Berghe H; Van de Ven WJ
    Genomics; 1994 Mar; 20(2):210-22. PubMed ID: 8020967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification of a rearranged form of the high-mobility group protein gene HMGIC in OsA-CI osteosarcoma cells.
    Kools PF; Van de Ven WJ
    Cancer Genet Cytogenet; 1996 Oct; 91(1):1-7. PubMed ID: 8908160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata.
    Gattas GJ; Quade BJ; Nowak RA; Morton CC
    Genes Chromosomes Cancer; 1999 Aug; 25(4):316-22. PubMed ID: 10398424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene.
    Kazmierczak B; Hennig Y; Wanschura S; Rogalla P; Bartnitzke S; Van de Ven W; Bullerdiek J
    Cancer Res; 1995 Dec; 55(24):6038-9. PubMed ID: 8521389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of FHIT transcripts in normal and malignant breast tissue.
    Bièche I; Latil A; Becette V; Lidereau R
    Genes Chromosomes Cancer; 1998 Dec; 23(4):292-9. PubMed ID: 9824201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.
    Ingvarsson S; Agnarsson BA; Sigbjornsdottir BI; Kononen J; Kallioniemi OP; Barkardottir RB; Kovatich AJ; Schwarting R; Hauck WW; Huebner K; McCue PA
    Cancer Res; 1999 Jun; 59(11):2682-9. PubMed ID: 10363992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of the common fragile site FRA3B does not affect FHIT expression.
    Michael D; Rajewsky MF
    Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The t(3;12)(q27;q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype.
    Rogalla P; Kazmierczak B; Meyer-Bolte K; Tran KH; Bullerdiek J
    Genes Chromosomes Cancer; 1998 Jun; 22(2):100-4. PubMed ID: 9598796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas.
    Berner JM; Meza-Zepeda LA; Kools PF; Forus A; Schoenmakers EF; Van de Ven WJ; Fodstad O; Myklebost O
    Oncogene; 1997 Jun; 14(24):2935-41. PubMed ID: 9205100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.